Spanning 279 hectares, the Kilinto Special Economic Zone (SEZ) in Addis Ababa is designed as a state-of-the-art hub for pharmaceutical manufacturing, offering modern infrastructure, international standards, and competitive incentives.
Together with our Ethiopia Desk Manager, Meles Gebrtensaye, we held fruitful discussions with the SEZ management team on how German investors can benefit from opportunities in local production, technology transfer, and regional market access.
Key Highlights
- Ethiopia imports 80% of its medicines, with 75% purchased by the government (EPSS).
- Market projected to grow from USD 1.6B (2020) to USD 3.6B (2030).
- SEZ currently 27% occupied, hosting 24 companies.
- Reliable infrastructure: 200 MW dedicated power, 15 GB internet, 6 boreholes supplying 289 L/sec, contamination-control facilities.
- Dedicated pharmaceutical manufacturing & packaging zone.
- Attractive incentives: up to 15 years tax exemption, customs duty exemptions, loss carry-forward, repatriation guarantees, and reduced utility costs.
- One-Stop Shop services (Customs, EIC, Banks, MOLSA, EFDA, Insurance) & only 12 km from Bole Airport.
- Investor support: long-term visas, streamlined permits, property ownership rights, and aftercare services.
Strategic Opportunities
With strong government commitment to making Ethiopia a leading pharmaceutical hub in Africa, the Kilinto SEZ offers German and international companies a gateway to a fast-growing healthcare market and regional export opportunities.
Special thanks to Tolossa Bedada Kenea, General Manager of Kilinto SEZ, for the insightful discussions and warm hospitality.
Together with our Ethiopia Desk Manager, Meles Gebrtensaye, we held fruitful discussions with the SEZ management team on how German investors can benefit from opportunities in local production, technology transfer, and regional market access.